Clinical trials begin for Bharat Biotech’s Covid-19 vaccine
Hyderabad-based Bharat Biotech on Friday announced that the Phase-I clinical trials of India’s first indigenous Covid-19 vaccine Covaxin began across the country on July 15. “This is a randomised, double-blind, placebo-controlled clinical trial on 375 volunteers in India,” the company said in a brief statement. The leading vaccine maker had announced on June 29 that … Read more